Clinical Trial

KSX01-TCRT Injection Project in Solid Tumors

Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
1\) Safety and efficacy of TCR-T cells in subjects with refractory/relapsed solid tumors. 2) The activation and proliferation of TCR-T cells in the subject, and the survival time.
Trial Details
NCT Number NCT05811975
Lead Sponsor TCRx Therapeutics Co.Ltd
Conditions TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors
Enrollment 50 participants
Start Date 2023-03-07
Primary Completion 2026-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-04-13